SubSpecialties  |   December 2016
An Update from the Society of Cardiovascular Anesthesiologists
Author Affiliations
  • Linda Shore-Lesserson, M.D., FAHA, FASE
    Society of Cardiovascular Anesthesiologists
Article Information
Cardiovascular Anesthesia / SubSpecialties
SubSpecialties   |   December 2016
An Update from the Society of Cardiovascular Anesthesiologists
ASA Monitor 12 2016, Vol.80, 46-48.
ASA Monitor 12 2016, Vol.80, 46-48.
One of the most dramatic and far-reaching advancements in surgical care in recent years is happening right now in the field of structural heart disease, and the impact on the anesthesiologist is significant.
Similar to the development of coronary stents and endovascular aortic procedures, cardiac surgeons and interventional cardiologists are now using a number of new, minimally invasive percutaneous interventions on valves and other structures of the heart, sparing many patients the need for open-heart surgery. For these procedures, the rate of technological advancement has been remarkable, and the role of the anesthesiologist is rapidly evolving.
The most current example is transcatheter aortic valve replacement (TAVR). The first procedure was performed in 2002 in France on a patient with aortic stenosis considered inoperable, too sick for cardiac operation. Clinical trials for high-risk patients began in the United States in 2006. One study in 2009 reported a 5.5-hour median procedure time,1  a 52 percent transfusion rate using general anesthesia, a pulmonary artery catheter and transesophageal echocardiography (TEE) monitoring.
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Affiliation & Institution
I have a potential conflict of interest
Comment Title

This feature is available to Subscribers Only
ASA Member Login or Create an Account ×